GTx Announces Webcast for Capesaris®(GTx-758) Analyst Day

GTx Announces Webcast for Capesaris®(GTx-758) Analyst Day

MEMPHIS, Tenn.--(BUSINESS WIRE)-- GTx, Inc. (NAS: GTXI) announced today a webcast discussing Capesaris®(GTx-758) and it's potential role in the treatment of advanced prostate cancer in men is scheduled for Friday, February 15th 2013, from 9:00am - 10:00am Eastern Time. The presentations will be conducted by an expert faculty panel to include: Phillip Kantoff, MD, Dana-Farber Cancer Institute/Brigham and Women's Hospital; Thomas Flaig, MD, University of Colorado School of Medicine; and Evan Yu, MD, Fred Hutchinson Cancer Research Center.

Register for the live webcast at (http://www.media-server.com/m/p/tseh66fk).




GTx, Inc.
Marc Hanover, 901-523-9700
President

KEYWORDS:   United States  North America  Tennessee

INDUSTRY KEYWORDS:

The article GTx Announces Webcast for Capesaris®(GTx-758) Analyst Day originally appeared on Fool.com.

Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.


Increase your money and finance knowledge from home

Understanding Stock Market Indexes

What does it mean when people say "the market is up 2%"?

View Course »

Small Cap Investing

Learn now to invest in small companies the right way.

View Course »

Add a Comment

*0 / 3000 Character Maximum